September 2021 DAIT Council-Approved Concepts

Concepts represent early planning stages for program announcements, requests for applications, notices of special interest, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.

NB: Council approval does not guarantee that a concept will become an initiative.

Table of Contents

Fiscal Year (FY) 2023 Concepts

Asthma and Allergic Diseases Cooperative Research Centers

For the published request for applications, check the December 23, 2021 announcement, Asthma and Allergic Diseases Cooperative Research Centers (U19, Clinical Trial Optional).

Development of Radiation/Nuclear Medical Countermeasures (MCMs) and Biodosimetry Devices

For the published broad agency announcement, check the December 17, 2021 solicitations, Development of Radiation/Nuclear Medical Countermeasures (MCMs) and Bio-dosimetry Devices.

Immune Drivers of Autoimmune Disease

For the published request for applications, check the February 24, 2022 Guide notice, Immune Drivers of Autoimmune Disease (IDAD) (U01, Clinical Trial Not Allowed).

Accelerating Progress in Celiac Disease Research

For the published notice of special interest, check the November 23, 2021 Guide notice, Notice of Special Interest (NOSI)—Accelerating Progress in Celiac Disease Research.

Molecular and Genetic Characterization of Inborn Errors of Immunity

For the published notice of special interest, check the November 29, 2021 Guide notice, Notice of Special Interest (NOSI)—Molecular and Genetic Characterization of Inborn Errors of Immunity.

Content last reviewed on